Japan-based Fujitsu and DT-Axis have announced the commencement of a collaboration aimed at advancing digital health. Th...
Japan-based Reprocell has announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Ban...
PHC Corporation’s Biomedical Division, a global provider of laboratory sample storage and cell cultivation solutio...
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...
US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...
Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to...
Japan-based Shimadzu Corporation has invested in A-wave Inc., a startup originating from The University of Osaka, throug...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Clinigen, a global leader in accelerating patient access to critical medicines, obtained the world's first prescription ...
Japan-headquartered Nxera Pharma has entered into a license agreement with a newly established independent company (NewC...
Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...
South Korea-based startup Sky Labs Inc. has entered into an exclusive distribution agreement with Otsuka Pharmaceut...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...
SBC Medical Group Holdings Incorporated, a global provider of comprehensive consulting and management services to medica...
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (I...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
Japan-based H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio have announced the availability of the Lu...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
Japan-based companies Otsuka Pharmaceutical Co. and Towa Pharmaceutical Co. have entered into an agreement to establish ...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
